Cancer Communications
indexed by SCI
BMC

[ Special series on Tumor angiogenesis ]
doi: 10.1186/s40880-016-0087-1
Twenty years after: the beautiful hypothesis and the ugly facts
Francesco Pezzella, Kevin Gatter and Chao-Nan Qian
Nuffield Division of Clinical Laboratory Science, Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford
[Abstract] The limited clinical benefits from current antiangiogenic therapy for cancer patients have triggered some critical thoughts and insightful investigations aiming to further elucidate the relationship between vessels and cancer. Tumors need blood perfusion but there are mounting evidences that angiogenesis alone does not explain it in all the neoplasms. In this editorial, for a special issue on tumor and vessels published in the Chinese Journal of Cancer, we briefly introduce the history of the evidences that solid tumors can sometimes obtain blood perfusion by alternative approaches other than sprouting angiogenesis, i.e., vessel co-option and vasculogenic mimicry. This editorial provides also the links to several most recently published discoveries and hypotheses on tumor interaction with blood vessels.
Chinese Journal of Cancer 2016, Volume: 35, Issue 2
[ PDF Full-text ]
[ Html full-text / Citation export] (BioMed Central)

[Google Scholar]


[ More articles of the special series on Tumor angiogenesis ]


Cite this article

Francesco Pezzella, Kevin Gatter and Chao-Nan Qian. Twenty years after: the beautiful hypothesis and the ugly facts. Chin J Cancer. 2016, 35:22. doi:10.1186/s40880-016-0087-1


Export citations

EndNote


SHARE THIS ARTICLE


Your Comments

  

 


Comments:


CJC Wechat 微信公众号


 

Editorial Manager


CC adopts ScholarOne Manuscripts to manage its submissions from Nov.1, 2019

 Submission Guidelines  

 

Reference style for  

 EndNote,
 Reference Manager



Editorial Manager


 

Year:

 

Month:

Advanced search

Subscription


CC is now published by Wiley

© Cancer Communications

651 Dongfeng Road East, Guangzhou 510060, P. R. China